Major players in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc, Shimadzu Corporation, Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric Company, Bio-Rad Laboratories Inc, Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc, Phenomenex, Jasco Inc, Hamilton Company, Tosoh Corporation, YMC CO LTD, Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd, Sartorius AG and Mitsubishi Chemical Corporation.
The global high-performance liquid chromatography market is expected to grow from $4.80 billion in 2021 to $5.29 billion in 2022 at a compound annual growth rate (CAGR) of 10.16%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The high-performance liquid chromatography market is expected to reach $6.53 billion in 2026 at a compound annual growth rate (CAGR) of 5.42%.
The high-performance liquid chromatography market consists of revenues earned by entities by HPLC systems, pumps, detectors, and fraction collectors.The market value includes the value of related goods sold by the service provider or included within the service offering.
Only goods and services traded between entities or sold to end consumers are included.
The high-performance liquid chromatography refers to an analytical technique of separating, identifying, and quantifying components in a mixture.The process relies on pumps which are used to move a pressured liquid solvent containing the sample combination through a column containing a solid adsorbent material.
This procedure allows for both quantitative and qualitative analysis.
North America was the largest region in the high-performance liquid chromatography market in 2021.Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the high-performance liquid chromatography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The main product of high-performance liquid chromatography are instruments, consumables, and accessories.The instruments product of high-performance liquid chromatography is instrument used to perform holding packing material (stationary phase) and pumping mobile phase in high-performance liquid chromatography.
Instruments in high-performance liquid chromatography refer to delivery systems, mobile phase/solvent reservoir, post-column apparatus, detector, data collection, output system, and others, that are applied in clinical research, diagnostics, forensic, and other applications, used by pharmaceutical and biotechnology industries, diagnostic laboratories, food and beverage industry, academic and research institutes and others end-users (environmental, forensic, chemicals and energy).
The increasing prevalence of chronic diseases and acute diseases is expected to propel the demand for the high performance lquid chromatography market.Chronic diseases are long-lasting sicknesses that often cannot be healed.
However, it is occasionally curable and controllable.The changing lifestyle, eating habits, and not maintaining body weight are the reason for chronic conditions; a few more prolonged chronic infections lead to cancerous risk.
Growing exposure to these diseases raises the need for high performance lquid chromatography for a patient to treat complex chronic diseases.For instance, In September 2020, a research report published by American Action Forum identified that the prevalence and cost of chronic disease in the United States are growing and will continue to rise as the disease prevalence among young people and children rises.
The increasing total cost of chronic disease in the United States reaches $3.7 trillion each year, approximately 19.6 percent of its gross domestic product, making it a severe issue in healthcare. Therefore increasing prevalence of chronic and actue diseases is driving the growth of the high performance lquid chromatography market.
Technological advancement is the key trend that is gaining popularity in the high-performance liquid chromatography market.High-performance liquid chromatography (HPLC) has been frequently utilized for antibiotic analysis as it outperforms conventional microbiological techniques in terms of specificity, sensitivity, and analysis time.
Recently, the market has witnessed ion exchange liquid chromatography techniques for detecting glycated hemoglobin (HbA1c) in blood samples.Ion exchange chromatography separates ions and polar compounds based on their affinity for ion exchangers.
Major companies operating in high-performance liquid chromatography focus on research and development to develop technologically advanced tools and solutions to strengthen their market position.For instance, In June 2021, Trivitron Healthcare, an India-based company operating in the manufacturing and supply of medical devices, introduced NANO H5 and NANO H110 for the detection of glycated hemoglobin (HbA1c), measures the amount of glucose (sugar) in blood samples using ion exchange liquid chromatography.
NANO H5 and NANO H110 are automated HPLC analyzer that offers dual test mode for the HbA1c test and Hb Variant detection. This new high-performance liquid chromatography analyzer detects HbA1c in less than three minutes. These HbA1c analyzers based on HPLC will be utilized to monitor diabetes, thalassemia, and hemoglobin variations.
In January 2022, Bruker Corporation, a US-based manufacturer of scientific instruments for molecular and materials research, acquired Prolab Instruments GmbH for an undisclosed amount.Through this acquisition, Bruker Corporation aims to strengthen its product portfolio in proteomics and metabolomics workflows of high-performance mass spectrometry systems and to improve mobile injection unit technology.
Prolab Instruments GmbH is a Switzerland-based company operating in high-performance liquid chromatography instruments.
The countries covered in the high-performance liquid chromatography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
The high-performance liquid chromatography market research report is one of a series of new reports that provides high-performance liquid chromatography market statistics, including industry global market size, regional shares, competitors with a high-performance liquid chromatography market share, detailed high-performance liquid chromatography market segments, market trends and opportunities, and any further data you may need to thrive in the high-performance liquid chromatography industry. This high-performance liquid chromatography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.